TORONTO, April 10, 2012 (GLOBE NEWSWIRE) -- GeneNews Limited (TSX:GEN), a company focused on developing and commercializing blood-based biomarker tests for the early detection of diseases and personalized health management, announced that Enzo
Enzo Biochem Inc. (NYSE: ENZ) announced today the filing of an application with
the New York State Department of Health for the first assay based on its
proprietary AmpiProbe nucleic acid detection platform. Upon approval, the
Company plans to...
Enzo Biochem, Inc. (NYSE: ENZ) today announced that the New York State Department of Health has approved Enzo Clinical Labs' use of the ColonSentry™ test for providing an assessment of a patient's risk of having colorectal cancer. The...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.